Ben Richardson, CEO at SulNOx, confident they can cost-effectively decarbonise commercial shipping. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCalnex Solutio. Regulatory News (CLX)

Share Price Information for Calnex Solutio. (CLX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 54.00
Bid: 53.00
Ask: 55.00
Change: 0.00 (0.00%)
Spread: 2.00 (3.774%)
Open: 54.00
High: 54.00
Low: 54.00
Prev. Close: 54.00
CLX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

FY24 Trading Update and Notice of Results

3 Apr 2024 07:00

RNS Number : 0498J
Calnex Solutions PLC
03 April 2024
 

This announcement contains inside information

 

03 April 2024

 

Calnex Solutions plc

("Calnex", the "Company" or the "Group")

 

FY24 Trading Update and Notice of Results

 

Calnex Solutions plc (AIM: CLX), a leading provider of test and measurement solutions for the global telecommunications and cloud computing markets, provides an update on trading for the year to 31 March 2024 ("FY24") and outlook for FY25.

 

Calnex anticipates the results for FY24 will be broadly in line with market expectations, with revenues of approximately £16.3 million and margins maintained. The Company's cost base has been adjusted, maintaining and focusing R&D spend to capitalise on the opportunities available to Calnex whilst controlling other costs. The Group's balance sheet remains strong, with cash as at 31 March 2024 of £11.9 million after investment in working capital in H2.

 

While the Group's performance has been affected by the well documented ongoing challenges in the telecoms sector, customer engagement levels have remained high, providing confidence that improvement in the telecoms market outlook will result in projects recommencing and customer spending resuming. Calnex is well placed to fulfil orders relating to these projects once activity levels increase.

 

The Board is encouraged by the level of positive engagement with customers on the Group's new product programmes and in particular expects that continued order growth from the defence and cloud computing sectors will enable Calnex to return to growth in FY25.

 

Positioned for growth in FY25 and beyond

 

Management has focused the Group's engineering programmes on opportunities showing the most near-term resilience and potential within the Group's established telecoms market and in the newer markets of cloud computing and defence.

 

Targeting growth in the telecoms market and long-term growth drivers intact

 

Within the telecoms market, the engineering programme is focused on the area of 800Gb/s synchronisation testing, an unmet need where there is growing customer demand. The Group anticipates a major new release in H2 FY25 to support leading edge 800Gb/s interface testing. Looking ahead, while the current challenges faced by the telecoms market are anticipated to continue throughout 2024, the Board is confident the transition to 5G and further development of O-RAN will drive a long-term transformation of the global telecoms infrastructure and demand for our lab synchronisation products.

 

Cloud computing and data centre markets represent growing opportunity

 

Calnex's newly marketed products focused on the cloud computing and data centre markets, SNE-X, SNE Ignite and NE-ONE, have seen encouraging levels of interest and initial orders. Over the medium term, the cloud computing market represents a significant additional opportunity for Calnex, given the investment into this market to support high growth in Artificial Intelligence (AI), virtual reality and increasing data centre demand. Measurement and testing is critical to performance in these areas. New opportunities are being assessed in network time monitoring, as well as data centre efficiency and effectiveness. The Group has also experienced good order levels for its application assurance offering, NE-ONE, in the defence, government and satellite markets and anticipates this will continue in FY25.

 

To maximise these opportunities, the Company is optimising its market approach for its suite of cloud focused offerings, bringing together its cloud infrastructure and cloud application teams, with a view to developing a consistent additional revenue stream.

 

Tommy Cook, Chief Executive Officer and founder of Calnex, said:

 

"In the face of a challenging telecoms market we have successfully adjusted the focus of our engineering programmes towards the markets showing the most resilience and opportunity, with positive customer conversations taking place across each of our new product programmes. The cloud computing market in particular represents an increasingly exciting opportunity and with the long-term growth drivers in the telecoms market remaining intact, we are well placed to return to growth in FY25 and beyond."

 

Notice of Results

 

The Company intends to announce audited results for the year ended 31 March 2024 on Tuesday 21 May 2024.

 

For more information, please contact:

 

Calnex Solutions plc

Via Alma

Tommy Cook, Chief Executive Officer

Ashleigh Greenan, Chief Financial Officer

Cavendish Capital Markets Limited - NOMAD

+44 (0)131 220 6939

Derrick Lee, Peter Lynch

 

Alma Strategic Communications

+ 44(0) 20 3405 0213

Caroline Forde, Joe Pederzolli

 

 

Overview of Calnex

 

Calnex Solutions designs, produces and markets test and measurement instrumentation and solutions for the telecoms and cloud computing industries. Calnex's portfolio enables R&D, pre-deployment and in-service testing for network technologies and networked applications, enabling its customers to validate the performance of the critical infrastructure associated with telecoms and cloud computing networks and the applications that run on it.

 

To date, Calnex has secured and delivered orders in 68 countries across the world. Customers include BT, China Mobile, NTT, Ericsson, Nokia, Intel, Qualcomm, IBM and Meta.

 

Founded in 2006, Calnex is headquartered in Linlithgow, Scotland, with additional locations in Belfast, Northern Ireland, Stevenage, England and California in the US, supported by sales teams in China and India. Calnex has a global network of partners, providing a worldwide distribution capability. 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTUUVNRSNUSRAR
Date   Source Headline
10th Apr 20247:00 amRNSNotice of Investor Presentation
3rd Apr 20247:00 amRNSFY24 Trading Update and Notice of Results
21st Feb 20249:28 amRNSExercise of Options
14th Feb 20241:08 pmRNSExercise of Options
12th Dec 20233:47 pmRNSPDMR Dealings
21st Nov 20237:00 amRNSInterim Results
1st Nov 202312:24 pmRNSChange of Nominated Adviser
26th Oct 20237:00 amRNSNotice of Investor Presentation
10th Oct 20233:17 pmRNSTrading Update and Notice of Results
25th Aug 20234:36 pmRNSPDMR Dealings
16th Aug 20231:22 pmRNSResult of AGM
16th Aug 20237:00 amRNSAGM Statement
11th Aug 20232:00 pmRNSLong-Term Incentive Plan Awards
17th Jul 20237:00 amRNSNotice of AGM
12th Jul 202312:05 pmRNSDirector/PDMR Dealings
12th Jun 20234:34 pmRNSPDMR Dealings
23rd May 20237:00 amRNSFY23 Final Results
11th May 20239:00 amRNSPDMR Dealings
4th May 20237:00 amRNSNotice of Results and Investor Presentation
14th Apr 20236:03 pmRNSPDMR Dealings
14th Apr 20233:24 pmRNSDirector Dealing
15th Mar 20231:15 pmRNSDirector Dealings
14th Mar 20234:00 pmRNSPDMR Dealings
7th Mar 20239:05 amRNSSecond Price Monitoring Extn
7th Mar 20239:00 amRNSPrice Monitoring Extension
7th Mar 20237:00 amRNSTrading Update
15th Feb 202310:59 amRNSPDMR Dealings
19th Jan 20239:56 amRNSPDMR Dealings
17th Jan 20239:56 amRNSDirector / PDMR Dealings
17th Jan 20239:52 amRNSHolding(s) in Company
17th Jan 20237:00 amRNSBoard Changes
13th Jan 20234:00 pmRNSDirector/PDMR Dealing
13th Dec 20222:15 pmRNSDirector / PDMR Dealings
22nd Nov 20227:00 amRNSInterim Results
21st Nov 20225:43 pmRNSDirector / PDMR Dealings
27th Oct 20227:00 amRNSNotice of Results and Investor Presentation
14th Oct 20223:53 pmRNSDirector/PDMR Shareholding
12th Oct 20221:29 pmRNSDirector / PDMR Dealings
15th Sep 20227:30 amRNSDirector/PDMR Dealing
17th Aug 20225:26 pmRNSResult of AGM
17th Aug 20227:00 amRNSAGM Statement
15th Aug 202210:26 amRNSDirector / PDMR Dealings
26th Jul 20223:33 pmRNSDirector / PDMR Shareholding
18th Jul 20227:00 amRNSNotice of AGM
14th Jul 20225:49 pmRNSDirector/PDMR Dealings
8th Jul 20226:01 pmRNSDirector / PDMR dealings
15th Jun 20227:00 amRNSExercise of Options
14th Jun 20227:00 amRNSBoard Update
6th Jun 20221:30 pmRNSDirector Dealing
24th May 20227:00 amRNSFY22 Final Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.